Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

Recent & Breaking News (TSXV:LBL.H)

IIROC Trading Halt - LBL

Canada NewsWire June 7, 2021

Lattice Announces Strategic Advisory Board

Business Wire March 31, 2021

Lattice Announces Strategic Cannabis Supply Agreement With Firehouse

Business Wire March 19, 2021

Lattice Biologics Reorganizes to Focus on Psychedelics and Cannabis Therapies

Business Wire March 15, 2021

Lattice Biologics Ltd. Announces Resignation of Director

Business Wire March 3, 2021

Lattice Biologics Ltd. Reports First Quarter 2021 Highlights

Business Wire March 1, 2021

 Lattice Biologics Ltd. Reports Fourth Quarter and Year End 2020 Highlights

Business Wire January 28, 2021

Lattice Unaware of Any Material Change

Business Wire January 5, 2021

COVID19 UPDATE - Lattice Biologics Announces Cessation of Patient Recruitment

Business Wire September 3, 2020

Lattice Biologics Ltd. Reports Q3 2020 Results

Business Wire August 31, 2020

Lattice Biologics Issues Shares and Warrants

Business Wire August 18, 2020

The Top Healthcare Bullboards: April - June 2020

Stockhouse Editorial June 17, 2020

Lattice Biologics Eliminates CAN$838,000 in Debt

Business Wire June 8, 2020

Lattice Biologics Ltd. Reports Second Quarter 2020 Results

Business Wire June 2, 2020

Lattice Biologics Update

Business Wire May 11, 2020

The Top Coronavirus-Related Small-Caps & Bullboards

Stockhouse Editorial April 27, 2020

Lattice Biologics Ltd. Announces Option Repricing

Business Wire April 15, 2020

Lattice Biologics Signs Definitive Agreement with Alumina Partners for $6 Million At-Will Offering Facility

Business Wire April 7, 2020

The Top Healthcare Bullboards: Jan - Mar 2020

Stockhouse Editorial March 23, 2020

Lattice Biologics Ltd. Announces Initial Recruitment of Patients for a Phase 1 Clinical Trial to Access Safety and Efficacy of AmnioBoost for Treatment of COVID-19

Business Wire March 17, 2020